Late Relapse After Allogeneic Bone Marrow Transplant In a Patient With Myelodysplasia

Area of Science:

• Hematology
• Oncology
• Stem Cell Transplantation

Background:

• Bone marrow transplantation is a potentially curative treatment for Myelodysplastic syndrome (MDS).
• Long-term disease-free survival post-transplant has traditionally implied cure.
• Recent data suggests late relapses can occur, challenging the definition of cure.

Purpose of the Study:

• To report a case of Myelodysplastic syndrome (MDS) with late relapse after bone marrow transplantation.
• To highlight the potential efficacy of a second transplant in such cases.

Main Methods:

• A patient with Myelodysplastic syndrome (MDS) underwent initial bone marrow transplantation.
• The patient experienced relapse more than 5 years after the first transplant.
• A second bone marrow transplantation was performed for the relapsed disease.

Main Results:

• The patient relapsed with Myelodysplastic syndrome (MDS) over 5 years post-initial bone marrow transplantation.
• The second bone marrow transplantation resulted in successful treatment of the relapsed MDS.

Conclusions:

• Myelodysplastic syndrome (MDS) relapse can occur significantly late after bone marrow transplantation.
• A second bone marrow transplant is a viable therapeutic option for patients experiencing late relapse.